LAS VEGAS, Oct. 12, 2023 /PRNewswire/ -- Cigna is expanding its Medicare Advantage (MA) presence to Nevada for the first time, launching in two counties in the Las Vegas area with a $0 premium plan that includes attractive extra benefits and access to a network of trusted providers. The plan will first be available to Medicare eligible customers during Medicare's Annual Enrollment Period (AEP), which begins Oct. 15 and continues through Dec. 7. It will be effective Jan. 1, 2024.
"MA plans are growing in popularity with older adults all across the country because they offer benefits not found in Original Medicare," said Ryan Kocher, Cigna Healthcare's Medicare Chief Growth Officer. "Our plans focus on helping older adults remain healthy and vital with access to high-quality care and attractive benefits at affordable costs."
Cigna Preferred Savings Medicare (HMO) is available in Clark and Nye counties. The plan offers the following benefits:
Cigna Healthcare also offers Medicare Supplement plans and standalone prescription drug plans across all of Nevada.
For more details about Cigna Healthcare's Medicare plans, please visit www.CignaMedicareInformation.com.
About Cigna Healthcare
Cigna Healthcare is a health benefits provider that advocates for better health through every stage of life. We guide our customers through the health care system, empowering them with the information and insight they need to make the best choices for improving their health and vitality. Products and services are provided exclusively by or through operating subsidiaries of The Cigna Group (NYSE:CI), including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth Health companies or their affiliates and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and others. Learn more at cignahealthcare.com.
Cigna Healthcare products and services are provided exclusively by or through operating subsidiaries of The Cigna Group. The Cigna names, logos, and marks, including THE CIGNA GROUP and CIGNA HEALTHCARE are owned by Cigna Intellectual Property, Inc. *Select benefits may not be available in all service areas without a monthly premium or without an additional monthly premium. Some plans may include these benefits under the monthly premium. Benefits, features and/or devices vary by plan/service area. Limitations, exclusions, and restrictions may apply. Contact the plan for more information. Subsidiaries of The Cigna Group contract with Medicare to offer Medicare Advantage HMO and PPO plans and Part D Prescription Drug Plans (PDP) in select states, and with select State Medicaid programs. Enrollment in a Cigna Healthcare product depends on contract renewal. © 2023 Cigna Healthcare
Media Contact:
Kelly Mathews
This email address is being protected from spambots. You need JavaScript enabled to view it.
423.260.9267
Last Trade: | US$333.01 |
Daily Change: | 4.56 1.39 |
Daily Volume: | 2,297,590 |
Market Cap: | US$92.630B |
October 31, 2024 September 12, 2024 September 12, 2024 August 01, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB